ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 610459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 610459; 2) Community: the network communities that were significantly associated with the response to NSC 610459; 3) Molecule: the relationships between components within communities and NSC 610459; 4) MDR: the compounds that were significantly associated with the NSC 610459.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0209467683758286 0.49386037
NSC 313681 Oxiperomide(USAN) 0.0209467683758286 -0.014141596
NSC 321491 Null 0.0209467683758286 -0.23131937
NSC 328410 Camptothecin Derivative 0.0209467683758286 0.71316821
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0209467683758286 0.53898026
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0209467683758286 0.45232302
NSC 45236 Null 0.0209467683758286 0.27857609
NSC 606499 Camptothecin Derivative 0.0209467683758286 0.93056252
NSC 619030 Analog of CC-1065 0.0209467683758286 0.67255748
NSC 633514 Null 0.0209467683758286 0.16418447
Total:64  Current:28    [First] [Prev] [Next] [Last]